1. Home
  2. ARDX vs NRK Comparison

ARDX vs NRK Comparison

Compare ARDX & NRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • NRK
  • Stock Information
  • Founded
  • ARDX 2007
  • NRK 2002
  • Country
  • ARDX United States
  • NRK United States
  • Employees
  • ARDX N/A
  • NRK N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • NRK Trusts Except Educational Religious and Charitable
  • Sector
  • ARDX Health Care
  • NRK Finance
  • Exchange
  • ARDX Nasdaq
  • NRK Nasdaq
  • Market Cap
  • ARDX 882.9M
  • NRK 824.4M
  • IPO Year
  • ARDX 2014
  • NRK N/A
  • Fundamental
  • Price
  • ARDX $6.55
  • NRK $9.96
  • Analyst Decision
  • ARDX Strong Buy
  • NRK
  • Analyst Count
  • ARDX 9
  • NRK 0
  • Target Price
  • ARDX $10.50
  • NRK N/A
  • AVG Volume (30 Days)
  • ARDX 3.2M
  • NRK 187.3K
  • Earning Date
  • ARDX 10-30-2025
  • NRK 01-01-0001
  • Dividend Yield
  • ARDX N/A
  • NRK 4.10%
  • EPS Growth
  • ARDX N/A
  • NRK N/A
  • EPS
  • ARDX N/A
  • NRK N/A
  • Revenue
  • ARDX $386,146,000.00
  • NRK N/A
  • Revenue This Year
  • ARDX $17.79
  • NRK N/A
  • Revenue Next Year
  • ARDX $27.82
  • NRK N/A
  • P/E Ratio
  • ARDX N/A
  • NRK N/A
  • Revenue Growth
  • ARDX 83.88
  • NRK N/A
  • 52 Week Low
  • ARDX $3.21
  • NRK $8.95
  • 52 Week High
  • ARDX $7.18
  • NRK $11.09
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 71.64
  • NRK 76.81
  • Support Level
  • ARDX $6.47
  • NRK $9.84
  • Resistance Level
  • ARDX $6.78
  • NRK $10.00
  • Average True Range (ATR)
  • ARDX 0.19
  • NRK 0.07
  • MACD
  • ARDX -0.05
  • NRK 0.05
  • Stochastic Oscillator
  • ARDX 67.18
  • NRK 94.15

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About NRK Nuveen New York AMT-Free Quality Municipal Income Fund

Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. Its investment objective is to provide current income exempt from regular federal, New York State, and New York City income taxes and from the federal alternative minimum tax applies to individuals and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: